Speaking to credibility, the company has done a number of animal studies at major academic centers -- Dr. Eva Harris, Professor of Public Health at UC Berkeley, Dr. Ken Rosenthal, Professor, Northeastern Ohio Universities of Medicine and Pharmacy, Dr Gus Kousoulas, Professor, Virology /Immunology at LSU, and Dr. Gene Olinger virologist at the USArmy Medical Research Institute of Infectious Diseases.
Dr Menon, who is affiliated with the Company, did several sets of influenza studies using the standard model as well as a few sets of HIV studies using the SCID-Hu Thy/Liv standard model. The staff at the Vietnam National Laboratory did the initial influenza studies. The initial HIV studies were done at Beth Israel Hospital in Boston.
In addition, Dr. Harris (considered the leading dengue researcher in the US) did the dengue hemorrhagic fever studies on a mouse model of her own design. She salvaged 50% of the animals who had dengue hemorrhagic fever, a lethal disease in her model. That was her first pass at the drug, without optimization.
Dr. Diwan has presented at multiple scientific conferences, including one sponsored by NIST, the National Institute of Standards and Technology. And also more recently at a seminar hosted by the Center for Biological Physics, jointly with the California NanoSystems Institute, a name of some prestige.
Although there has been no interest in publishing, they did write a chapter in a scientific book about nanotechnology but only because they were asked to do so.
Incidentally, between all of the principals, they have taken 12 drugs to market, have published hundreds of papers and have something in the neighborhood of 45 patents.
News 
Market Data 
Discover 
